Lyophilized Injectable Drugs Market (By Packaging Type: Specialty Packaging, Point-Of-Care Reconstitution, Single-Use Vials, Others; By Type of Delivery: Single-step Devices, Multi-step Devices, Prefilled Diluent Syringes, Proprietary Reconstitution Devices; By Indication: Infectious Diseases, Autoimmune Diseases, Metabolic Conditions, Others; By End-user: Ambulatory Surgical Centers, Hospitals, Specialty Clinics, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 160

Introduction

The global lyophilized injectable drugs market is projected to worth $4,350.3 Million by 2026 and the market is projected to showcase 6.9% CAGR during the forecast period. The lyophilized injectable drugs market is expected to grow at a rapid pace owing to the increase in development of pipeline of lyophilized injectable drugs.

Market Dynamics

Growing health awareness and rise in demand for lyophilized injectable drugs in various medical conditions such as metabolic and cardiac diseases are the major driving factors that is boosting the growth of the lyophilized injectable drugs market. Also, governments stringent regulation and low emission policies across the globe encourage the usage of lyophilized injectable drugs that integrates low rolling resistant tires and aerodynamics that helps in fuel savings as well as reduce carbon emissions which are the key factors driving the growth of the global lyophilized injectable drugs market.

Market Insights

The lyophilized injectable drugs are costly in terms of manufacturing process, therefore, the key manufacturers in the global market are investing on R&D activities to offer a substitute method that will help to extend the product’s shelf life. Though, this substitute method requires development related to absorbent stability and biological activity of the material. For instance, for instance, in September 2015, Purdue University has introduced lyophilization association named LyoHUB with an objective to develop advanced freeze-drying technology to make it safer and more affordable for pharmaceuticals and biotech products.

Market Classification

The global lyophilized injectable drugs market is segmented into fivemain segment that include packaging type, type of delivery, indication, end-user and region. On the basis of packaging type,the global lyophilized injectable drugs market is segmented into specialty packaging, point-of-care reconstitution, single-use vials, and others. On the basis of type of delivery,the global lyophilized injectable drugs market is segmented intosingle-step devices, multi-step devices, prefilled diluent syringes, and proprietary reconstitution devices. On the basis of indication, the global lyophilized injectable drugs market is segmented into infectious diseases, autoimmune diseases, metabolic conditions, and others. On the basis of the end-user,the global lyophilized injectable drugs market is segmented into ambulatory surgical centers, hospitals, specialty clinics, and others. On the basis of region, the global lyophilized injectable drugs market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Based on packaging type, the global lyophilized injectable drugs market ismajorly segmented into three sub-segments, which arespecialty packaging, point-of-care reconstitution, single-use vials. The specialty packaging segment is predicted to lead the global lyophilized injectable drugs market owing to the wide spread of lyophilized injectable drugs in several chronic diseases.

Regional Insights

The North America region is predicted to dominate the lyophilized injectable drugs market owing to technological advancement and huge investment by manufacturers in research and development in this region. Also, due to the huge presence of contract manufacturing and services inexpected to drive the lyophilized injectable drugs market in North America region.

Asia Pacific is projected to grow at high CAGR and expected to create growth opportunities for manufacturers as there is increase in healthcare spending in developing countries. Countries such as Singapore, Malaysia and Thailand are expected to create significant opportunities in the healthcare industry.Moreover, the improved medical infrastructure facilities is likely to boost the demand of the lyophilized injectable drugs market.

Market Participants

Some of the key vendors operating in the lyophilized injectable drugs market are Schott AG, CIRON Drugs & Pharmaceuticals Pvt. Ltd, Mylan N.V., Baxter, Vetter Pharma, Dickinson and Company, SHL Group, B. Braun Melsungen AG, Jubilant HollisterStier, and others.

Key vendors are highly focused on investment in research and development activities to manufacture innovative lyophilized injectable drugs using advanced technologies. Furthermore, the manufacturers operating in the global lyophilized injectable drugs market are strategically focused product innovation and partnership, merger and acquisition of other players in healthcare industry in order to increase their product portfolio as well as expand their customer base globally.

Market Segmentation

Market By Packaging Type

  • Specialty Packaging
  • Point-Of-Care Reconstitution
  • Single-Use Vials
  • Others

Market By Type of Delivery

  • Single-step Devices
  • Multi-step Devices
  • Prefilled Diluent Syringes
  • Proprietary Reconstitution Devices

Market By Indication

  • Infectious Diseases
  • Autoimmune Diseases
  • Metabolic Conditions
  • Others

Market By End-user

  • Ambulatory Surgical Centers
  • Hospitals
  • Specialty Clinics
  • Others

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA


Related Reports

Medical Nonwoven Disposables Market (By Product: Incontinence Hygiene Products, Surgical Non-woven Products; By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Platform) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

The global medical nonwoven disposables market is forecasted to grow at a CAGR of 6.6% over the forecast time frame and reach around US$ 26.1 billion by 2026. The report provides analysis of global medical non-woven disposables market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.  Market Insights Nonwovens are a unique category of textile product enginee

Plastic Surgery Instruments Market (By Type: Handheld Surgical Instruments, Electrosurgical Instruments; By Procedure: Face and Head Procedures, Breast Procedures, Body and Extremities Procedures, Reconstruction Surgeries) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global plastic surgery instruments market size is anticipated to reach around US$ 1.7 billion by 2026 and expected to grow at a CAGR of 8.5% from period 2019 to 2026. Plastic surgery involves the restoration, replacement, alteration and rehabilitation of body regions, such as the head, skin, musculoskeletal, breast and others. The two main kinds of plastic surgery are cosmetic and reconstructive. Cosmetic o

Upper Limb Prosthetics Market (By Component: Prosthetic Arm, Prosthetic Wrist, Prosthetic Shoulder, Prosthetic Elbow, Terminal Devices; By Product: Body Powered Prosthetic Devices, Passive Prosthetic Devices, Hybrid Prosthetic Devices, Myoelectric Prosthetic Devices; By Cause: Vascular Disease and Diabetes, Trauma, Cancer; By End Use: Ambulatory Surgical Centers, Hospitals, Prosthetic Clinics) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global upper limb prosthetics market size is expected to worth US$ 1.9 billion by 2026 and poised to grow at a CAGR around 10.5 % from period 2019 to 2026. The prothetics of the upper limbs have gone a long way from their ancient origins to advanced and advanced protheses of today's moments.  Today, the highest prothesis implants consist of aluminum, plastics and sophisticated composite components. The

MRI-Guided Neurosurgical Ablation Market (By Product: Accessories, MRI-guided Laser Ablation Systems, MRI-guided Focused Ultrasound Systems, MRI-guided Radiofrequency Ablation Systems; By End-use: Clinics, Ambulatory Surgical Centers, Hospitals) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global MRI-guided neurosurgical ablation market is forecasted to grow at a CAGR around 4.3% from period 2019 to 2026 and reach around US$ 5.4 billion by 2026. The report provides analysis of global MRI-guided Neurosurgical Ablation market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.  Market Insights An gr

Self-Monitoring Blood Glucose Devices Market (By Product: Continuous Glucose Monitors, Lancets, Self-monitoring Blood Glucose Meters, Testing Strips; By Application: Type 2 Diabetes, Type 1 Diabetes, Gestational Diabetes; By End-Use: Home Usage, Hospitals, Diagnostic Clinics & Centers) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

Introduction According to Acumen Research and Consulting, The global self-monitoring blood glucose devices market size is expected to reach US$ 19 billion by 2026 and market is growing at a CAGR of 5 % from 2019 to 2026. Diabetes is a clinical disorder in which the blood glucose level rises owing to the pancreas ' incapacity to generate insulin. Monitoring glucose is one of the most important measures in the leadership of diabetes

Ovarian Cancer Diagnostics Market (By Diagnosis Type: Imaging, Biopsy, Blood Test, Others; By Cancer Type: Germ Cell Tumor, Stromal Cell Tumor, Epithelial Tumor, Others; By End-Use: Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes, Others) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

Introduction  According to Acumen Research and Consulting, the global ovarian cancer diagnostics market is forecasted to grow at striking CAGR around 5.9 % over the forecast time frame and reach around US$ 1.8 billion by 2026. One of the most prevalent kinds of cancer in females is ovarian cancer. It is a cancer which begins in the ovaries. Ovary is a woman reproductive organ that contains eggs or ova. There are two ovaries i

Cart Summary